From the Guidelines
Children under two years of age should not use Nasonex (mometasone furoate nasal spray) as it is not approved for this age group. According to the clinical practice guideline on allergic rhinitis 1, the age approved for Nasonex is ≥2 years, with a recommended dose of 1 spray per nostril every day for children aged 2-11 years.
Key Considerations
- The safety and efficacy of Nasonex have not been adequately studied in children under 2 years of age.
- Corticosteroid nasal sprays like Nasonex may affect growth and development differently in very young children.
- Alternative treatments, such as saline nasal sprays or humidifiers, may be recommended by a pediatrician for children under 2 years of age experiencing nasal congestion or allergy symptoms.
Treatment Options for Children Under 2
- Saline nasal sprays: can help loosen and clear mucus from the nasal passages.
- Humidifiers: can add moisture to the air, relieving congestion and cough.
- Other interventions: specifically designed for infants, such as nasal aspirators or suction devices, may be recommended by a pediatrician. It is essential to consult with a pediatrician to determine the best course of treatment for children under 2 years of age experiencing nasal congestion or allergy symptoms, as they can recommend age-appropriate options and ensure the child's safety and well-being 1.
From the FDA Drug Label
Do not use ■ in children under 2 years of age ■ Children age 2 to 11 An adult should supervise use
Nasonex (mometasone) is not recommended for children under 2 years of age.
- The FDA drug label for mometasone (IN) explicitly states that it should not be used in children under 2 years of age 2.
- The dosage instructions for children start at age 2, indicating that children under 2 should not use the product 3.
From the Research
Nasonex Usage in Children Under Two
- There are no studies provided that directly address the use of Nasonex in children under two years old.
- The studies provided have age restrictions, such as patients 12 years of age or older 4, 5, or do not specify the age range of the patients 6, 7, 8.
- None of the studies mention the safety or efficacy of Nasonex in children under two years old, suggesting that there may be limited research on this topic.
- Without direct evidence, it is unclear whether Nasonex can be used in children under two years old, and any decisions regarding its use in this age group should be made with caution and under the guidance of a healthcare professional.